The Research Policy Network is presently focused on:
Fostering cutting-edge scientific discovery, supporting large-scale collaborative projects, and championing patient-centred innovation. Now the time has come to bring European cancer care and research to the next level, leading to improved outcomes for all cancer patients in Europe.
At the European Cancer Summit 2025 on 19-20 November, we'll reflect on the progress achieved and define the next level of ambition for European cancer research. Join us!
Check out here the recording for 2024’s session.
The European Cancer Organisation’s Research Policy Network, chaired by Professor Christine Chomienne, has published a new Green Paper on EU investment in cancer research.
It sets out ideas to improve how EU-supported cancer research is planned, governed, funded, and translated into better outcomes for patients and society. It builds on the momentum of Europe’s Beating Cancer Plan and the EU Cancer Mission and invites debate on optimising opportunities for the next EU multiannual financial framework (2028–2034).
Read more here.
In 2024, Network participants had the opportunity to share input on the future activities and priorities for European cancer research and innovation policy at large. Reflections included:
Ambitious, cutting-edge research is essential to turn the tide against cancer, allowing more effective innovations in diagnosis and treatment to benefit patients and societies.
The Research Policy Network of the European Cancer Organisation brings together stakeholders from across the cancer community to examine all policy needs faced by scientists, healthcare professionals, patients, and decision-makers along the cancer research pathway. This will focus on basic and translational research, health service and public health research, clinical, implementation, across Europe and its benefits to cancer patients and health systems.
To learn more or to support our work, please contact us